A 52 Week Randomized, Controlled, Open Label, Multicenter, Multinational, Parallel, Treat to Target Trial Comparing Efficacy and Safety of SIBA and Insulin Glargine Both Administered Once Daily

  • Karounos, Dennis (PI)

Detalles del proyecto

EstadoFinalizado
Fecha de inicio/Fecha fin9/1/098/31/11